US Patent Issued to Alpha-9 Oncology on Sept. 8 for "Gastrin-releasing peptide receptor (GRPR)-targeted compounds and uses thereof" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,175, issued on Sept. 8, was assigned to Alpha-9 Oncology Inc. (Vancouver, Canada).

"Gastrin-releasing peptide receptor (GRPR)-targeted compounds and uses thereof" was invented by Jutta Wanner (Vancouver, Canada), Chengcheng Zhang (Vancouver, Canada), Kaveh Matinkhoo (Vancouver, Canada), Stephen Barigye (Vancouver, Canada) and Hsiou-Ting Kuo (Vancouver, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to gastrin-releasing peptide receptor (GRPR)-targeted compounds and their use for imaging and treatment of diseases or conditions characterized by expression of the gastrin-releasing peptide receptor."

The patent was ...